MetaCap

Iambic Therapeutics Statistics

NASDAQ: IAMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

13.11-1.15 (-8.06%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Iambic Therapeutics by the numbers

Iambic Therapeutics has a market capitalization of $621.4 million based on 47.40M shares outstanding. With trailing EPS of $-2.69, Iambic Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.7% below its 50-day average and 9.7% below its 200-day average.

Average daily trading volume is 714.92K shares, or about $9.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

IAM valuation vs. peer median

IAM compared with the median of 8 peer companies
MetricIAMPeer medianDifference
Market cap$621.42M$586.77M+6%
Avg. volume714.92K692.19K+3%

Peer median across 8 companies: SRZN, CGEM, FDMT, ENTX, DBVT, ATTO, SLDB, AURA.

Valuation

Price and trading

Previous close
14.26
Open
13.98
Day range
12.77 – 14.00
52-week range
9.60 – 25.00
Beta
—
Volume
281.91K

Dividends and events

Annual dividend
None
Next earnings date
Nov 16, 2026

Additional statistics

Market Cap
621.42M
Forward Pe
-4.31
Eps
-2.69
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
25.00
Week52 Low
9.60
Avg Volume
714.92K
Shares Outstanding
47.40M
Ma50
14.52
Ma200
14.52
Earnings Date
Nov 16, 2026
Pct From52w High
-47.56%
Pct From52w Low
36.56%

Related